Literature DB >> 3380554

Concerning the management of pain associated with herpes zoster and of postherpetic neuralgia.

Robert B King1.   

Abstract

This simple method of achieving substantial pain control in patients with documented herpes zoster and postherpetic neuralgia has been effective in each of the patients in whom it has been used (the most recent 12 cases have been summarized for this report). It has been more effective than narcotic analgesics, oral anti-inflammatory analgesics, sedatives, tranquilizers, TENS, hypnosis and the wide variety of operative measures we have tried in the past. Although it was initially used pragmatically, there is now a reasonable rationale for its effectiveness that can be proposed based on more recent insights into the anatomy and neurophysiology of cutaneous nociceptors and the neuropharmacology of aspirin. In view of the widely held persuasion that the management of pain syndromes associated with herpes zoster (especially severe postherpetic neuralgia) is an unsatisfactory and frustrating venture, it seemed reasonable to report these more favorable clinical observations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380554     DOI: 10.1016/0304-3959(88)90206-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  5 in total

1.  Iontophoresis using a local anesthetic for the treatment of pediatric acute herpetic pain.

Authors:  Kenji Kodama; Yoshiro Sakaguchi; Takato Morioka; Chiaki Miyazaki; Masamune Tominaga; Etsuko Kanna; Shosuke Takahashi
Journal:  J Anesth       Date:  1998-06       Impact factor: 2.078

Review 2.  Post-herpetic neuralgia in older patients. Incidence and optimal treatment.

Authors:  D Bowsher
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

Review 3.  Herpes zoster and postherpetic neuralgia. Optimal treatment.

Authors:  R W Johnson
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 4.  Treatment of postherpetic neuralgia: an update.

Authors:  G E Kanazi; R W Johnson; R H Dworkin
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

5.  [Pain therapy in herpes zoster and post-zoster neuralgia.].

Authors:  T Zenz; M Zenz; M Tryba
Journal:  Schmerz       Date:  1994-03       Impact factor: 1.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.